Literature DB >> 15607223

Targeting of a histone acetyltransferase domain to a promoter enhances protein expression levels in mammalian cells.

T H J Kwaks1, R G A B Sewalt, R van Blokland, T J Siersma, M Kasiem, A Kelder, A P Otte.   

Abstract

Silencing of transfected genes in mammalian cells is a fundamental problem that probably involves the (in)accessibility status of chromatin. A potential solution to this problem is to provide a cell with protein factors that make the chromatin of a promoter more open or accessible for transcription. We tested this by targeting such proteins to different promoters. We found that targeting the p300 histone acetyltransferase (HAT) domain to strong viral or cellular promoters is sufficient to result in higher expression levels of a reporter protein. In contrast, targeting the chromatin-remodeling factor Brahma does not result in stable, higher protein expression levels. The long-term effects of the targeted p300HAT domain on protein expression levels are positively reinforced, when also anti-repressor elements are applied to flank the reporter construct. These elements were previously shown to be potent blockers of chromatin-associated repressors. The simultaneous application of the targeted p300HAT domain and anti-repressor elements conveys long-term stability to protein expression. Whereas no copy number dependency is achieved by targeting of the p300HAT domain alone, copy number dependency is improved when anti-repressor elements are included. We conclude that targeting of protein domains such as HAT domains helps to facilitate expression of transfected genes in mammalian cells. However, the simultaneous application of other genomic elements such as the anti-repressor elements prevents silencing more efficiently.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15607223     DOI: 10.1016/j.jbiotec.2004.07.012

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  9 in total

1.  Design, Construction, and Validation of Histone-Binding Effectors in Vitro and in Cells.

Authors:  Stefan J Tekel; Cassandra Barrett; Daniel Vargas; Karmella A Haynes
Journal:  Biochemistry       Date:  2018-06-11       Impact factor: 3.162

2.  Porcine germline genome engineering.

Authors:  Luhan Yang; George Church; Hong-Ye Zhao; Lusheng Huang; Yangbin Gao; Hong-Jiang Wei; Geoffrey Yang
Journal:  Proc Natl Acad Sci U S A       Date:  2021-04-30       Impact factor: 11.205

Review 3.  Current state and recent advances in biopharmaceutical production in Escherichia coli, yeasts and mammalian cells.

Authors:  Aleš Berlec; Borut Strukelj
Journal:  J Ind Microbiol Biotechnol       Date:  2013-02-06       Impact factor: 3.346

4.  Regulatory Elements in Vectors for Efficient Generation of Cell Lines Producing Target Proteins.

Authors:  O Maksimenko; N B Gasanov; P Georgiev
Journal:  Acta Naturae       Date:  2015 Jul-Sep       Impact factor: 1.845

Review 5.  The epigenome: the next substrate for engineering.

Authors:  Minhee Park; Albert J Keung; Ahmad S Khalil
Journal:  Genome Biol       Date:  2016-08-31       Impact factor: 13.583

6.  Molecular structures guide the engineering of chromatin.

Authors:  Stefan J Tekel; Karmella A Haynes
Journal:  Nucleic Acids Res       Date:  2017-07-27       Impact factor: 16.971

7.  Intraclonal protein expression heterogeneity in recombinant CHO cells.

Authors:  Warren Pilbrough; Trent P Munro; Peter Gray
Journal:  PLoS One       Date:  2009-12-23       Impact factor: 3.240

Review 8.  Epigenetic Editing: targeted rewriting of epigenetic marks to modulate expression of selected target genes.

Authors:  Marloes L de Groote; Pernette J Verschure; Marianne G Rots
Journal:  Nucleic Acids Res       Date:  2012-09-21       Impact factor: 16.971

9.  Components from the Human c-myb Transcriptional Regulation System Reactivate Epigenetically Repressed Transgenes.

Authors:  Cassandra M Barrett; Reilly McCracken; Jacob Elmer; Karmella A Haynes
Journal:  Int J Mol Sci       Date:  2020-01-14       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.